178 related articles for article (PubMed ID: 15694876)
1. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
J Pain; 2005 Feb; 6(2):98-106. PubMed ID: 15694876
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.
Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
4. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
[TBL] [Abstract][Full Text] [Related]
5. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.
Dworkin RH; Jensen MP; Gammaitoni AR; Olaleye DO; Galer BS
J Pain; 2007 Feb; 8(2):118-26. PubMed ID: 16949878
[TBL] [Abstract][Full Text] [Related]
6. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
Jensen MP
Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
[TBL] [Abstract][Full Text] [Related]
7. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
[TBL] [Abstract][Full Text] [Related]
8. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome.
Jensen MP; Gammaitoni AR; Olaleye DO; Oleka N; Nalamachu SR; Galer BS
J Pain; 2006 Nov; 7(11):823-32. PubMed ID: 17074624
[TBL] [Abstract][Full Text] [Related]
9. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
[TBL] [Abstract][Full Text] [Related]
10. Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?
Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
J Pain; 2006 Sep; 7(9):644-53. PubMed ID: 16942950
[TBL] [Abstract][Full Text] [Related]
11. The pain quality response profile of oxymorphone extended release in the treatment of low back pain.
Gould EM; Jensen MP; Victor TW; Gammaitoni AR; White RE; Galer BS
Clin J Pain; 2009 Feb; 25(2):116-22. PubMed ID: 19333156
[TBL] [Abstract][Full Text] [Related]
12. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response.
Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS
Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726
[TBL] [Abstract][Full Text] [Related]
13. Treatment satisfaction in osteoarthritis and chronic low back pain: the role of pain, physical and emotional functioning, sleep, and adverse events.
Dworkin RH; Jensen MP; Gould E; Jones BA; Xiang Q; Galer BS; Gammaitoni AR
J Pain; 2011 Apr; 12(4):416-24. PubMed ID: 20869325
[TBL] [Abstract][Full Text] [Related]
14. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.
Jensen MP; Chiang YK; Wu J
Clin J Pain; 2009 May; 25(4):286-92. PubMed ID: 19590476
[TBL] [Abstract][Full Text] [Related]
15. The pain quality response profile of a corticosteroid injections and heated lidocaine/tetracaine patch in the treatment of shoulder impingement syndrome.
Jensen MP; Trudeau JJ; Radnovich R; Galer BS; Gammaitoni AR
Clin J Pain; 2015 Apr; 31(4):342-8. PubMed ID: 25329142
[TBL] [Abstract][Full Text] [Related]
16. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.
Galer BS; Sheldon E; Patel N; Codding C; Burch F; Gammaitoni AR
Curr Med Res Opin; 2004 Sep; 20(9):1455-8. PubMed ID: 15383194
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
Tremont-Lukats IW; Hutson PR; Backonja MM
Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
[TBL] [Abstract][Full Text] [Related]
19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
20. Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
Überall MA; Müller-Schwefe GH
Curr Med Res Opin; 2012 Jun; 28(6):901-9. PubMed ID: 22506624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
